1. Impact of the baloxavir-resistant polymerase acid I38T substitution on the fitness of contemporary influenza A(H1N1)pdm09 and A(H3N2) strains;Checkmahomed;J. Infect. Dis.,2020
2. Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir;Chesnokov;J. Infect. Dis.,2020
3. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection;Fukao;J. Antimicrob. Chemother.,2019
4. Baloxavir and treatment-emergent resistance: public health insights and next steps;Gubareva;J. Infect. Dis.,2020
5. Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons;Gubareva,2019